Visser Jeldican, de Jong J M B Vianney, de Visser Marianne
Department of Neurology, Academic Medical Center, Amsterdam, The Netherlands.
Neurology. 2008 Feb 26;70(9):723-7. doi: 10.1212/01.wnl.0000302187.20239.93.
Since its first description more than a century ago, there has been much debate about the diagnostic entity progressive muscular atrophy (PMA). Initially, PMA included all forms of progressive amyotrophy. With the identification of several myogenic and neurogenic diseases and the recognition of amyotrophic lateral sclerosis (ALS), PMA was deemed to disappear as a nosologic entity at the end of the 19th century. In the last century, various other lower motor neuron syndromes were distinguished which may previously have been designated as cases of PMA. In contrast, several observations provided evidence that PMA can be linked both clinically and pathologically to ALS. Therefore, PMA should be considered as a syndromal subtype within a clinical spectrum of motor neuron diseases.
自一个多世纪前首次被描述以来,关于诊断实体进行性肌肉萎缩(PMA)一直存在诸多争论。最初,PMA包括所有形式的进行性肌萎缩。随着几种肌源性和神经源性疾病的识别以及肌萎缩侧索硬化症(ALS)的认识,PMA在19世纪末被认为作为一个疾病分类实体而消失。在上个世纪,区分出了各种其他的下运动神经元综合征,这些综合征以前可能被指定为PMA病例。相比之下,一些观察结果提供了证据,表明PMA在临床和病理上都可与ALS相关联。因此,PMA应被视为运动神经元疾病临床谱内的一种综合征亚型。